ghk cu human studies Thermodynamically stable ionic liquid microemulsions pioneer pathways for topical delivery and peptide application GLOW | GHK-Cu / TB-500

A method of preventing gait abnormalities in a patient with Parkinson's disease or of improving or restoring to normal the gait of a patient with Parkinson's disease, comprising the step of administering to said patient an amount of one or more hepatocyte growth factor mimics sufficient to prevent, improve or restore to normal said gait, said one or more hepatocyte growth factor mimics having a general structural formula 1 2 3 where Ri is one of an N-acyl group, a substituted or unsubstituted phenyl, a norleucine group, and an amino acid selected from tyrosine, phenylalanine, aspartic acid, arginine, isoleucine, serine, histidine, glycine, cysteine, methionine, tryptophan, lysine norvaline, ornithine, and s-benzyl cysteine

They form a vicious cycle

Sloppy reconstitution damages peptide bonds and reduces potency

Axons can vary in length some are microscopic, while others stretch from the spine to the toes and they send signals at speeds ranging from 2 to 200 miles per hour